Lincoln Nadauld, M.D., Ph.D.
Lincoln Nadauld, M.D., Ph.D., is the CEO of Culmination Bio, a clinical insights company spun out of Intermountain Healthcare. Prior to coming on as Culmination Bio’s full-time CEO, Dr. Nadauld served as the Chief of Precision Health at Intermountain Healthcare, where he founded the Intermountain Precision Genomics program with a vision of finding solutions to improve health and disease through genomics and precision medicine without increasing costs. With this vision in mind, he oversaw the clinical implementation of precision genomics across Intermountain’s 24 hospitals and 160 physician clinics. He also facilitated research aimed at developing a better understanding of the human genome.